World Trade Center Exposure Linked to Increased DNA Methylation
By Elana Gotkine HealthDay Reporter
THURSDAY, Sept. 5, 2024 -- World Trade Center (WTC) exposure is associated with increased DNA methylation, which may contribute to breast cancer, according to a study published in the June issue of Environmental Epidemiology.
Stephanie Tuminello, Ph.D., M.P.H., from the NYU Grossman School of Medicine in New York City, and colleagues examined the DNA methylation profiles of WTC-exposed community members who remained cancer-free versus those who developed breast cancer. The study included 64 WTC-exposed women (32 cancer-free, 32 with breast cancer) and 32 WTC-unexposed women from the NYU Women's Health Study (16 cancer-free and 16 with prediagnostic breast cancer).
The researchers found that compared with unexposed participants, WTC-exposed women more often had hypermethylated cytosine-phosphate-guanine probe sites (14.3 versus 4.5 percent). In WTC-exposed groups (breast cancer patients and cancer-free individuals), cancer-related pathways were overrepresented. Forty-seven epigenetically dysregulated genes were identified among WTC-exposed breast cancers compared with the unexposed breast cancer patients. A network was formed from these genes, including Wnt/β-catenin signaling genes WNT4 and TCF7L2; dysregulation of these genes contributed to cancer immune evasion.
"WTC exposure is associated with global and site-specific DNA methylation changes. This was observed among cancer-free WTC-exposed survivors as well as those with breast cancer," the authors write. "Several cancer-related genes and pathways appear to be impacted, and, specifically, WTC exposure may compromise the ability of the immune system to identify and eliminate cancer cells contributing to cancer immune evasion."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Swept-Source Anterior Segment OCT Can Help Distinguish Early Childhood Glaucoma
FRIDAY, May 23, 2025 -- The noninvasive swept-source anterior-segment optical coherence tomography (SS-ASOCT) can diagnose early-onset childhood glaucoma, according to a study...
Semaglutide Plus Intensive Behavioral Therapy Most Beneficial for Weight Loss
FRIDAY, May 23, 2025 -- Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in...
Artificial Intelligence Flags Interval Breast Cancers Visible at Screening
FRIDAY, May 23, 2025 -- Artificial intelligence (AI) more often flags and accurately localizes interval breast cancers (IBCs) that are visible at screening than true interval or...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.